Abiopharma

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

Hycroft rapporteert een netto contante waarde van USD 10 miljard op basis van technisch rapport tegen spotprijzen en zet de ontwikkeling van de hoogwaardige zilvervondsten Brimstone en Vortex voort USA - Nederlands APAC - English USA - English USA - English USA - Deutsch

JEF INVESTIGATION: Investigation Launched into Jefferies Financial Group Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026

BHP Announces Rail Transportation Agreements with CN and CPKC to Bring Jansen Potash to Global Customers

Decent Holding Reports Preliminary Unaudited RMB 55.1 Million Revenue and 387 New Community Locations Through May 2026; Advances an AI-Powered AgeTech Ecosystem

BHP annonce la conclusion daccords de transport ferroviaire avec le CN et le CPKC pour acheminer la potasse de Jansen vers ses clients internationaux

DexCom, Inc. - Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value